Non-Small Cell Lung Cancer, Version 3.2022

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non???Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, pri -mary treatment, surveillance for relapse, and subsequent treat-ment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and action-able mutations.

Automated summary

This passage introduces the recommended management for non-small cell lung cancer (NSCLC) in the NCCN Clinical Practice Guidelines, with a focus on targeted therapies for patients with metastatic NSCLC and actionable mutations.